Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-21-000017)

Filing Details

Accession Number:: 0000711377-21-000017
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-27 14:26:38
Reporting Period:: 2021-04-23

Accepted Time:: 2021-04-27 14:26:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188987	A Terri Morrical			No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-23	1,121	$62.70	38,696	No	4	M	Direct
Common Stock	Disposition	2021-04-26	1,121	$96.97	37,575	No	4	S	Direct
Common Stock	Acquisiton	2021-04-26	800	$62.70	38,375	No	4	M	Direct
Common Stock	Disposition	2021-04-26	800	$97.09	37,575	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right to Buy)	Disposition	2021-04-23	1,121	$0.00	1,121	$62.70
Common Stock	Common Stock (Right to Buy)	Disposition	2021-04-26	800	$0.00	800	$62.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
88,879		2023-12-01	No	4	M	Direct
88,079		2023-12-01	No	4	M	Direct

Footnotes

Options were granted on 11/1/2018, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant